Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Patrick Horne"'
Autor:
Haesuk Park, Carolyn Brown, Debbie L. Wilson, Pei-Lin Huang, Pilar Hernández-Con, Patrick Horne, Amie Goodin, Amanda Joseph, Rich Segal, Roniel Cabrera, Robert L. Cook
Publikováno v:
Preventive Medicine Reports, Vol 32, Iss , Pp 102138- (2023)
The likelihood of clinicians prescribing direct-acting antiviral (DAA) therapy for patients with chronic hepatitis C virus (HCV) and substance use disorder (SUD) was assessed via a survey emailed throughout the United States to clinicians (physicians
Externí odkaz:
https://doaj.org/article/b7d45ca4180645e6aa279270b2bb95f8
Autor:
Elizabeth Flood-Grady, Virginia C. Clark, Angie Bauer, Lauren Morelli, Patrick Horne, Janice L. Krieger, David R. Nelson
Publikováno v:
Contemporary Clinical Trials Communications, Vol 8, Iss C, Pp 62-66 (2017)
Introduction: Although registries can rapidly identify clinical study participants, it is unknown which follow up methods for recruiting are most effective. We examined the efficacy of three communication strategies for recruiting and enrolling patie
Externí odkaz:
https://doaj.org/article/3d66e1b2ceff4ad290166b4c0441ef2b
Autor:
Haesuk Park, Carolyn Brown, Debbie L. Wilson, Pei-Lin Huang, Pilar Hernandez-Con, Patrick Horne, Amie Goodin, Amanda Joseph, Rich Segal, Roniel Cabrera, Robert L. Cook
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Journal of Hepatology. 77:S310-S311
Autor:
Patrick Horne, Anquenette P Sloan, K. Rajender Reddy, Mandana Khalili, Donna M. Evon, Juhi S Moon, Mark S. Sulkowski, Larry Michael, Scott Kixmiller, Michael W. Fried, David R. Nelson, Mitchell L. Shiffman, Meichen Dong, Monika Vainorius, Jama M. Darling, Jodi B Segal, Dawn Fishbein, Joy Peter, Paul W. Stewart, Summer Wadsworth, Kenneth E. Sherman, Brian L. Pearlman, Andrew J. Muir, Giuseppe Morelli, Federico Hinestrosa, Adrian M. Di Bisceglie, Prioritize Study Team, Anna S. Lok
Publikováno v:
Hepatology (Baltimore, Md.). 74(6)
Background and aims Multiple direct-acting antiviral (DAA) regimens are available to treat HCV genotype 1 infection. However, comparative effectiveness from randomized controlled trials of DAA regimens is unavailable. Approach and results We conducte
Autor:
Patrick Horne
Publikováno v:
DC I/O 2020.
Publikováno v:
Proceedings of the Water Environment Federation. 2018:4102-4109
Autor:
Patrick Horne, Janice L. Krieger, Angie Bauer, Elizabeth Flood-Grady, Virginia Clark, Lauren Morelli, David R. Nelson
Publikováno v:
Contemporary Clinical Trials Communications, Vol 8, Iss C, Pp 62-66 (2017)
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications
Introduction Although registries can rapidly identify clinical study participants, it is unknown which follow up methods for recruiting are most effective. We examined the efficacy of three communication strategies for recruiting and enrolling patien
Autor:
Patrick Horne
Publikováno v:
Clinical liver disease. 13(6)
Autor:
Roniel Cabrera, Consuelo Soldevila-Pico, Roberto J. Firpi, Patrick Horne, David R. Nelson, Rennie Mills, Alpna R. Limaye, Giuseppe Morelli, Virginia Clark
Publikováno v:
Alimentary Pharmacology & Therapeutics. 37:91-97
Sorafenib is currently the only approved systemic therapy shown to have efficacy in the treatment of advanced hepatocellular carcinoma (HCC). Recent studies suggest that hepatitis C (HCV)-related HCC patients derive more clinical benefit from sorafen